TX HB3299 | 2013-2014 | 83rd Legislature

Status

Spectrum: Partisan Bill (Democrat 1-0)
Status: Introduced on March 8 2013 - 25% progression, died in committee
Action: 2013-03-25 - Referred to Public Health
Pending: House Public Health Committee
Text: Latest bill text (Introduced) [HTML]

Summary

Relating to a study regarding the provision of the drug palivizumab through the Medicaid vendor drug program to premature newborns.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Relating to a study regarding the provision of the drug palivizumab through the Medicaid vendor drug program to premature newborns.

Sponsors


History

DateChamberAction
2013-03-25HouseReferred to Public Health
2013-03-25HouseRead first time
2013-03-08HouseFiled

Subjects


Texas State Sources


Bill Comments

feedback